Re: OTC Expert & Grey Market Restrictions
in response to
by
posted on
Nov 22, 2022 11:14AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Whatever there is ongoing with ZHCLF, the stock already traded 226, 230 shares in the first 5 minutes of trading this morning, thus far.
I forget the short position here. Could we be witnessing a tree-shaking before a short squeeze?